ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

UBS cuts Klarna to Neutral on guidance cut, executive exits

Analysts slash price targets after Klarna slashes GMV guidance by $6 bln annually and executives depart. Stock down 50% year-to-date.

PA
Priya Anand · Equities & Earnings Desk · 23 Aug 2026 · 14:51 · 1 min read
Share
UBS cuts Klarna to Neutral on guidance cut, executive exits

UBS downgraded Klarna from Buy to Neutral on Sunday, citing weaker growth prospects and executive departures, reducing its price target to $16 from $23.

The Swiss bank’s move follows Klarna’s second-quarter earnings report, which showed a 31% weekly stock decline to $14.33 and a 50% year-to-date drop, leaving shares just above their 52-week low of $12.06.

BMO Capital, Morgan Stanley and TD Cowen also lowered their price targets for the buy-now-pay-later firm, with BMO reducing its target to $15 from $19, Morgan Stanley to $17 from $21, and TD Cowen to $18 from $19. TD Cowen maintained a Hold rating, while Needham reiterated its Hold recommendation.

Klarna’s guidance revision cut its second-half 2026 gross merchandise volume (GMV) outlook by roughly $3.4 billion at the upper end, excluding currency effects, with an estimated annualized impact of about $6 billion. The company also lowered its full-year GMV forecast to $150 billion from over $155 billion.

Second-quarter earnings showed a profit of $0.01 per share, beating TD Cowen’s estimate of a $0.03 loss and the consensus forecast of a $0.05 loss.

Executive departures added to concerns, with Klarna’s CFO and CMO set to leave in the coming quarters. The company highlighted weaker international growth, particularly in Germany, though it pointed to new distribution partnerships with Apple, expanding card programs and an early-stage U.S. fair financing business as potential positives.

Separately, BTIG Research noted that Affirm Holdings’ asset-backed securities delinquencies for its 2025-X2 cohort have reached record highs at nine months, exceeding prior cohorts at the same stage.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
ADVERTISEMENT